https://vital.seals.ac.za/vital/access/manager/Index en-us 5 https://vital.seals.ac.za/vital/access/manager/Repository/vital:58199 Sun 21 Apr 2024 21:38:03 SAST ]]> https://vital.seals.ac.za/vital/access/manager/Repository/vital:58209 Sun 21 Apr 2024 21:29:32 SAST ]]> https://vital.seals.ac.za/vital/access/manager/Repository/vital:58203 Sun 21 Apr 2024 21:27:37 SAST ]]> https://vital.seals.ac.za/vital/access/manager/Repository/vital:58196 87% had one (or fewer) test missing. Results suggested a similar factor structure to prior PennCNB studies in Western contexts, and expected age and sex effects were apparent. Furthermore, a similar profile of schizophrenia was observed, with neurocognitive deficits most pronounced for executive functions, especially attention, as well as memory, social cognition, and motor speed relative to complex cognition and sensorimotor speed. Conclusions: Results support the feasibility of implementing a culturally adapted computerized neurocognitive battery in sub-Saharan African settings and provide evidence supporting the concurrent validity of the translated instrument. Thus, the PennCNB is implementable on a large scale in non-Western contexts, shows expected factor structure, and can detect cognitive deficits associated with neuropsychiatric disorders. Obtaining valid measures of cognition by nonspecialized proctors is especially suitable in resource-limited settings, where traditional testing is prohibitive. Future work should establish normative standards, test–retest reliability, and sensitivity to treatment.]]> Sun 21 Apr 2024 21:25:26 SAST ]]>